Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 4

Thyroid dysfunction in chronically transfused adults with β-thalassemia major

Pages
707–712
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thyroid dysfunction was categorized as primary hypothyroidism (thyroid-stimulating hormone (TSH)>5.6 mU/L and serum-free thyroxine (FT4)5.6 mU/L) or secondary hypothyroidism (FT4

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aims to determine the prevalence and severity of thyroid dysfunction in adult β-thalassemia major (BTM) patients and to investigate its relationship with the frequency of transfusions, serum ferritin levels, and adequacy of oral chelation therapy.Material and Methods: This study included 62 adult patients diagnosed BTM and had been receiving regular blood transfusions for at least 1 year.
📊
Key Findings & Data:Iron load was defined as the serum ferritin level.
💡
Conclusion & Impact:Thyroid dysfunction was categorized as primary hypothyroidism (thyroid-stimulating hormone (TSH)>5.6 mU/L and serum-free thyroxine (FT4)5.6 mU/L) or secondary hypothyroidism (FT4
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This study aims to determine the prevalence and severity of thyroid dysfunction in adult β-thalassemia major (BTM) patients and to investigate its relationship with the frequency of transfusions, serum ferritin levels, and adequacy of oral chelation therapy.Material and Methods: This study included 62 adult patients diagnosed BTM and had been receiving regular blood transfusions for at least 1 year. Iron load was defined as the serum ferritin level. Thyroid dysfunction was categorized as primary hypothyroidism (thyroid-stimulating hormone (TSH)>5.6 mU/L and serum-free thyroxine (FT4)5.6 mU/L) or secondary hypothyroidism (FT4

🔖

Cite This Article

ŞAHİN, H. H., DOĞAN, İ. (2022). Thyroid dysfunction in chronically transfused adults with β-thalassemia major. Annals of Medical Research, Cilt: 26 - Sayı: 4, 707–712. https://ajindex.com/articles/447078

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005;353:1135-46
  2. De Sanctis V, Eleftheriou A, Malaventura C. Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev 2004;2:249-55
  3. Cavallo L, Licci D, Acquafredda A, et al. Endocrine involvement in children with beta-thalassaemia major. Transverse and longitudinal studies. I. Pituitary-thyroidal axis function and its correlation with serum ferritin levels. Acta Endocrinol (Copenh) 1984;107:49-53
  4. De Sanctis V, Vullo C, Katz M, et al. Endocrine complications in thalassaemia major. Prog Clin Biol Res 1989;309:77-83
  5. Magro S, Puzzonia P, Consarino C, et al. Hypothyroidism in patients with thalassemia syndromes. Acta Haematol 1990;84:72-6
  6. Sabato AR, de Sanctis V, Atti G, et al. Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Arch Dis Child 1983;58:120-7
  7. Depaz G, Deville A, Coussement N, et al. [Thyroid function in thalassemia major]. Ann Pediatr (Paris) 1985;32:809-11
  8. Masala A, Meloni T, Gallisai D, et al. Endocrine functioning in multitransfused prepubertal patients with homozygous beta-thalassemia. J Clin Endocrinol Metab 1984;58:667-70
  9. Zervas A, Katopodi A, Protonotariou A, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid 2002;12:151-4
  10. Landau H, Matoth I, Landau-Cordova Z, et al. Cross sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) 1993;38:55-61
  11. De Sanctis V, Soliman A, Yassin M. Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview. Curr Diabetes Rev 2013;9:332-41
  12. Pérignon F, Brauner R, Souberbielle JC, et al. [Growth and endocrine function in major thalassemia]. Arch Fr Pediatr 1993;50:657-63
  13. Jensen CE, Tuck SM, Old J, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol 1997;59:76-81
  14. Belhoul KM, Bakir ML, Saned MS, et al. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Ann Hematol 2012 91:1107-14
  15. Isik P, Yarali N, Tavil B, et al. Endocrinopathies in Turkish childr